tirzepatide side How to Manage Effects Mounjaro (Tirzepatide) Side Effects: Common

Lancet 398 , 1431556 (2021)

Zepbound, a weekly weight loss injection approved by the FDA, is effective for managing obesity, but Aetna recently removed it from coverage in many plans unless used for conditions like sleep apnea

The FDA approved it as Zepbound for chronic weight management in November 2023 and as Mounjaro for type 2 diabetes in May 2022

PlexusDx sources all tirzepatide from licensed 503A compounding pharmacies that follow these standards, ensuring your medication maintains its full potency throughout the labeled shelf life

This activation sends signals that reduce hunger and increase feelings of fullness after eating smaller portions